nonprofit logo

Queens-Long Island Renal Institute

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 264827558 ✦ New hyde park, NY ✦ Designated as a 501(c)(3)

Overview

What is Queens-Long Island Renal Institute?

Queens-Long Island Renal Institute is a charitable organization situated in New Hyde Park, New York. The institute specializes in providing renal replacement therapy services, specifically hemodialysis, to individuals suffering from end-stage renal disease (ESRD). With a team of 80 licensed and trained professionals, they offer treatments six days a week, divided into four patient shifts. To ensure affordability, they bill Medicare, Medicaid, and other third-party payers. In 2022, the institute served 315 patients in-center and initiated home hemodialysis services for three patients. The organization's mission is to provide the finest quality of care, utilizing advanced technology, and upholding uncompromised dignity in a comfortable setting, ensuring the well-being of its dialysis patients.


Official website here: www.qliri.org

Is Queens-Long Island Renal Institute legitimate?

Queens-Long Island Renal Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Queens-Long Island Renal Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,994,351

For more financial information, click here


Official website here: www.qliri.org

What is the mission statement of Queens-Long Island Renal Institute?

The Queens-Long Island Renal Institute is dedicated to providing dialysis patients with the highest quality of care, utilizing state-of-the-art technology, and ensuring uncompromised dignity, all in a comfortable setting. Their mission is to assure that patients undergoing dialysis treatment receive the best possible care, with a strong emphasis on their comfort and well-being. The organization prioritizes adhering to all regulatory standards, ensuring that treatments are administered by licensed and trained professionals. The Queens-Long Island Renal Institute offers in-center hemodialysis services to patients suffering from end-stage renal disease (ESRD), operating six days a week in various patient shifts. In 2022, the institution served 315 patients and also initiated its home hemodialysis services, catering to the needs of three patients.


Official website here: www.qliri.org

Who is the CEO of Queens-Long Island Renal Institute?

Michael Rosenblut is the President/Ceo of Queens-Long Island Renal Institute. The CEO's salary of Queens-Long Island Renal Institute is $0 and their total compensation is $2,070,197.


Official website here: www.qliri.org

What is the revenue of Queens-Long Island Renal Institute?

Queens-Long Island Renal Institute's revenue in 2022 was $4,895,470.


Official website here: www.qliri.org

Who are the executives of Queens-Long Island Renal Institute and what are their salaries?

The average compensation at Queens-Long Island Renal Institute during 2022 was $24,929. There are 80 employees and 9 volunteers at Queens-Long Island Renal Institute.

Here are 14 key members and their salaries (Queens-Long Island Renal Institute's CEO's salary is $0 and their total compensation is $2,070,197):

    Michael Rosenblut (President/Ceo)
  • Compensation: $0
  • Related: $1,951,820
  • Other: $118,377

    • Robert Werner (Cfo/Evp For Operations)
  • Compensation: $0
  • Related: $850,948
  • Other: $92,097

    • Geraldine Ramos (Director Of Patient Care Services)
  • Compensation: $122,586
  • Related: $0
  • Other: $47,579

    • Roberto Alindogan (Hemodialysis Rn)
  • Compensation: $105,130
  • Related: $0
  • Other: $14,039

    • Tahira Khan (Rn - Home Hemo Coordinator)
  • Compensation: $100,786
  • Related: $0
  • Other: $9,589

    • Robert Sterling (Chairman) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael L Denhoff (Vice Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Gary Granoff (Vice Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jerry Landsberg (Vice Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Nina Koppelman (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Philip Kaplan (Assistant Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Sheryl Silverstein Dmd (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lee Charles (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Leonard Tanzer (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.qliri.org

    Where can I find the form 990 for Queens-Long Island Renal Institute?

    The Queens-Long Island Renal Institute’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.qliri.org

    Learn more at the official website: www.qliri.org

    Mission Statement of Queens-Long Island Renal Institute

    Queens-Long Island Renal Institute, as a charitable organization, is dedicated to ensuring that dialysis patients receive the highest quality of care, utilizing state-of-the-art technology, and maintaining uncompromised dignity, all in a comfortable setting. This nonprofit organization's mission is centered around providing renal replacement therapy services for individuals suffering from end-stage renal disease (ESRD).

    The Queens-Long Island Renal Institute strives to deliver exceptional care to its patients, who undergo hemodialysis treatments six days a week, divided into four shifts. The healthcare professionals who work at this institution are all licensed and trained, adhering to both state and federal regulations to ensure the best possible care for the patients. The institute also bills Medicare, Medicaid, and other third-party payers for the services provided. In 2022, the Queens-Long Island Renal Institute served 315 patients throughout the year. Beyond its in-center hemodialysis services, the institute also expanded its offerings in 2022 with the introduction of home hemodialysis services, serving three patients.

    Impact

    This information is meant to be a general summary of Queens-Long Island Renal Institute. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    Queens-Long Island Renal Institute's impact can be seen in the lives of the 315 patients it served in 2022. By providing in-center hemodialysis to individuals suffering from end-stage renal disease, this organization played a vital role in ensuring these patients received the necessary treatment to maintain their health and well-being. Additionally, the institute's recent expansion into offering home hemodialysis services further highlights its commitment to improving the quality of care and accessibility for those in need of renal replacement therapy. Through its efforts, Queens-Long Island Renal Institute is making a tangible difference in the lives of individuals facing challenging health circumstances in the New Hyde Park community and beyond.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $1,906
  • Program Service Revenue: $4,876,577
  • Gross Receipts: $4,895,470

    • Assets and Liabilities:
  • Total Assets: $3,365,776
  • Total Liabilities: $648,354
  • Net Assets: $2,717,422
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    MEDICARE

    Revenue

    $2,758,557

    OTHER PATIENT SERVICE

    Revenue

    $2,019,242

    MEDICAID

    Revenue

    $98,778

    Organization Details

    Founding Year

    2009

    Principal Officer

    Michael Rosenblut

    Main Address

    271-11 76TH AVENUE, NEW HYDE PARK, NY, 11040

    NTEE Category

    Code: E20 - Health

    If you are a representative of Queens-Long Island Renal Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.